Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program

Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?

(2013) Steven A. Narod et al.   BREAST CANCER RESEARCH AND TREATMENT

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations

(2012) K Passaperuma et al.   BRITISH JOURNAL OF CANCER

Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway

(2012) P Møller et al.   CLINICAL GENETICS

Prospective Study of Breast Cancer Incidence in Women With aBRCA1orBRCA2Mutation Under Surveillance With and Without Magnetic Resonance Imaging

(2011) Ellen Warner et al.   JOURNAL OF CLINICAL ONCOLOGY

BRCA1-Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study

(2010) Adriana J. Rijnsburger et al.   JOURNAL OF CLINICAL ONCOLOGY

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

(2010) Andrew Tutt et al.   LANCET

Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy

(2009) Tomasz Byrski et al.   JOURNAL OF CLINICAL ONCOLOGY

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

(2008) Kelly A. Metcalfe et al.   INTERNATIONAL JOURNAL OF CANCER